Caffeic acid protects against IL-1β-induced inflammatory responses and cartilage degradation in articular chondrocytes

Biomed Pharmacother. 2018 Nov:107:433-439. doi: 10.1016/j.biopha.2018.07.161. Epub 2018 Aug 10.

Abstract

Osteoarthritis (OA) is a common articular disease that features cartilage loss and destruction. It has been confirmed that inflammation plays major roles in the progression of osteoarthritis. Caffeic acid (CA), a key dietary nutrient commonly found in coffee, has shown its anti-inflammatory properties in various inflammation diseases. However, the effects of CA in osteoarthritis remain explored. Here we investigated the effects of CA on IL-1β induced increased expression of inflammatory factors as well as the degradation of Collagen II and aggrecan in rat chondrocytes. CA prevented the cartilage damage induced by IL-1β in vivo organ culture of articular cartilage. Besides, the IL-1β induced increased production of inflammation factors such as iNOS and COX2 could be inhibited by CA. Additionally, CA could also suppress IL-1β induced expression of cartilage matrix catabolic enzymes such as ADAMTS5 and MMPs. Moreover, CA could prevent IL-1β induced degradation of Collagen II and aggrecan in chondrocytes. Furthermore, CA inhibited NF-κB activity and the activation of JNK pathway. This study reveals that CA inhibits IL-1β induced inflammation responses through suppression of NF-κB and MAPK related JNK signaling pathways. These results demonstrate that CA may provide new avenues for osteoarthritis treatment in future.

Keywords: ADAMTS5; Caffeic acid; MAPK; MMPs; NF-κB; Osteoarthritis.

MeSH terms

  • ADAMTS5 Protein / metabolism
  • Aggrecans / metabolism
  • Animals
  • Caffeic Acids / pharmacology*
  • Cartilage, Articular / pathology*
  • Cell Survival / drug effects
  • Chondrocytes / drug effects
  • Chondrocytes / enzymology
  • Chondrocytes / pathology*
  • Collagen Type II / metabolism
  • Cyclooxygenase 2 / metabolism
  • Inflammation / pathology*
  • Interleukin-1beta / adverse effects*
  • Interleukin-1beta / metabolism
  • MAP Kinase Signaling System / drug effects
  • NF-kappa B / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Protective Agents / pharmacology*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Aggrecans
  • Caffeic Acids
  • Collagen Type II
  • Interleukin-1beta
  • NF-kappa B
  • Protective Agents
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
  • ADAMTS5 Protein
  • caffeic acid